Trial Profile
FREERIDE-STUDY Freeway randomized angioplasty study Prospective, Randomized, Controlled, Multicentre, Open Study Release of Paclitaxel during PTA versus PTA alone for the treatment of de-novo occluded, stenotic or reoccluded, restenotic superficial femoral (SFA) or popliteal arteries
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Ischaemia; Peripheral arterial disorders
- Focus Therapeutic Use
- Acronyms FREERIDE-STUDY
- Sponsors Eurocor
- 17 Sep 2014 Interim results (n=84) presented at the 26th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
- 26 Aug 2014 New trial record